CABACabaletta BioCABA info
$2.38info3.03%24h
Global rank20010
Market cap$101.98M
Change 7d-13.45%
YTD Performance-89.44%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Business data

    Cabaletta Bio (CABA) Stock Overview

    Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease. Its product candidate pipeline also includes MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; CABA-201, a 4-1BB-containing CD19-CAR T investigational therapy, for the treatment of severe autoimmune diseases; PLA2R-CAART, a discovery stage product to treat patients with PLA2R-associated membranous nephropathy; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. It has a collaboration with the University of Pennsylvania and the Children's Hospital of Philadelphia. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.

    CABA Stock Information

    Symbol
    CABA
    Address
    2929 Arch StreetPhiladelphia, PA 19104United States
    Founded
    -
    Trading hours
    9:30 AM - 4:00 PM ET
    Website
    https://www.cabalettabio.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    267 759 3100

    Cabaletta Bio (CABA) Price Chart

    -
    Value:-

    Cabaletta Bio Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $2.38
    N/A
    Market Cap
    $101.98M
    N/A
    Shares Outstanding
    42.85M
    N/A
    Employees
    92.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org